Earnings calendar/DNTH
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter Dianthus Therapeutics, Inc. /DE/ has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$-0.90
Est. $-0.85 · -6.3%
Revenue
$761,000
Est. $297,182 · +156.1%
Net income
$-50.2M
As filed
EPS YoY
-2.3%
vs quarter ended 2025-06-30
Revenue YoY
+294.3%
vs quarter ended 2025-06-30
Next report
Nov 5, 2026
Third-party calendar date, not confirmed by a company filing · est. EPS $-0.94
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-4.25
2025-09-30 through 2026-06-30
TTM revenue
$1.9M
2025-09-30 through 2026-06-30
Filed quarters
38
On record here
EPS at or above estimate (4Q)
25%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-04 | $-0.90 | $761,000 | -2.3% | +294.3% | $-0.85 | -6.3% |
| 2026-03-31Q1 FY2026 | 2026-05-05 | $-0.85 | $463,000 | -3.7% | -60.2% | $-1.17 | +27.4% |
| 2025-12-31Q4 FY2025 | 2026-03-09 | $-1.53 | $284,000 | -101.3% | -78.6% | $-0.98 | -56.1% |
| 2025-09-30Q3 FY2025 | 2025-11-05 | $-0.97 | $396,000 | -31.1% | -81.8% | $-0.86 | -12.8% |
| 2025-06-30Q2 FY2025 | 2025-08-07 | $-0.88 | $193,000 | -72.5% | -89.6% | $-0.86 | -2.3% |
| 2025-03-31Q1 FY2025 | 2025-05-12 | $-0.82 | $1.2M | -51.9% | +33.1% | $-0.86 | +4.7% |
| 2024-12-31Q4 FY2024 | 2025-03-11 | $-0.76 | $1.3M | -104.7% | +190.2% | $-0.85 | +10.6% |
| 2024-09-30Q3 FY2024 | 2024-11-07 | $-0.74 | $2.2M | +80.4% | +135.1% | $-0.59 | -25.4% |
| 2024-06-30Q2 FY2024 | 2024-08-08 | $-0.51 | $1.9M | +96.0% | +92.3% | $-0.55 | +6.5% |
| 2024-03-31Q1 FY2024 | 2024-05-09 | $-0.54 | $874,000 | +93.3% | +83.6% | $-0.43 | -25.6% |
| 2023-12-31Q4 FY2023 | 2024-03-21 | $16.16 | $457,000 | +170.3% | -61.1% | $-1.11 | +1555.9% |
| 2023-09-30Q3 FY2023 | 2023-11-09 | $-3.78 | $924,000 | +57.5% | -21.2% | $-0.51 | -641.2% |
| 2023-06-30Q2 FY2023 | 2023-08-03 | $-12.73 | $969,000 | -4289.7% | — | $-0.80 | -1491.3% |
| 2023-03-31Q1 FY2023 | 2023-05-15 | $-8.10 | $476,000 | -1976.9% | — | $-6.40 | -26.6% |
| 2022-12-31Q4 FY2022 | 2023-03-23 | $-22.99 | $1.2M | -7316.1% | — | $-4.10 | -460.8% |
| 2022-09-30Q3 FY2022 | 2022-11-03 | $-8.90 | $1.2M | -2866.7% | — | $-4.64 | -91.8% |
| 2022-06-30Q2 FY2022 | 2022-08-04 | $-0.29 | $0 | +9.4% | — | $-5.44 | +94.7% |
| 2022-03-31Q1 FY2022 | 2022-05-16 | $-0.39 | $0 | -8.3% | — | $-5.09 | +92.3% |
| 2021-12-31Q4 FY2021 | 2022-03-08 | $-0.31 | $0 | +11.4% | — | — | — |
| 2021-09-30Q3 FY2021 | 2021-11-04 | $-0.30 | $0 | +18.9% | — | — | — |
| 2021-06-30Q2 FY2021 | 2021-08-05 | $-0.32 | $0 | +33.3% | — | — | — |
| 2021-03-31Q1 FY2021 | 2021-05-06 | $-0.36 | $0 | +29.4% | — | — | — |
| 2020-12-31Q4 FY2020 | 2021-03-03 | $-0.35 | $0 | +40.7% | — | — | — |
| 2020-09-30Q3 FY2020 | 2020-11-05 | $-0.37 | $0 | +31.5% | — | — | — |
| 2020-06-30Q2 FY2020 | 2020-08-06 | $-0.48 | $0 | 0.0% | — | — | — |
| 2020-03-31Q1 FY2020 | 2020-05-07 | $-0.51 | $0 | -15.9% | — | — | — |
| 2019-12-31Q4 FY2019 | 2020-03-03 | $-0.59 | $0 | -18.0% | — | — | — |
| 2019-09-30Q3 FY2019 | 2019-11-13 | $-0.54 | $0 | -10.2% | — | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-08 | $-0.48 | $0 | +84.7% | — | — | — |
| 2019-03-31Q1 FY2019 | 2019-05-09 | $-0.44 | $0 | +90.3% | — | — | — |
| 2018-12-31Q4 FY2018 | 2019-03-19 | $-0.50 | $0 | +86.1% | — | — | — |
| 2018-09-30Q3 FY2018 | 2018-11-08 | $-0.49 | $0 | +85.8% | — | — | — |
| 2018-06-30Q2 FY2018 | 2018-08-09 | $-3.13 | $0 | +64.8% | — | — | — |
| 2018-03-31Q1 FY2018 | 2019-03-19 | $-4.53 | $0 | -26.2% | — | — | — |
| 2017-12-31Q4 FY2017 | 2019-03-19 | $-3.59 | $0 | — | — | — | — |
| 2017-09-30Q3 FY2017 | 2018-11-08 | $-3.44 | $0 | — | — | — | — |
| 2017-06-30Q2 FY2017 | 2018-08-09 | $-8.90 | $0 | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2019-03-19 | $-3.59 | $0 | — | — | — | — |
Need DNTH data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.